Low Dose Mesenchymal Stem Cells (MSCs)

DRUG2 trials

Sponsors

Medical University of South Carolina

Conditions

System; Lupus ErythematosusSystemic Lupus Erythematosus

Phase 1

Pilot Trial of Mesenchymal Stem Cells for Systemic Lupus Erythematosus

CompletedNCT03171194

Medical University of South CarolinaSystem; Lupus Erythematosus

Start: 2017-04-27End: 2018-10-25Updated: 2019-05-02

Phase 2

Phase 2 Trial of Mesenchymal Stem Cells in Systemic Lupus Erythematosus (MiSLE)

CompletedNCT02633163

Medical University of South CarolinaSystemic Lupus Erythematosus

Start: 2018-11-18End: 2026-02-03Updated: 2026-08-24

Related Papers

Safety, immunological effects and clinical response in a phase I trial of umbilical cord mesenchymal stromal cells in patients with treatment refractory SLE

Lupus Science & Medicine2022-07-0142 citations